inv(2)(p23q35) ATIC/ALK
2001-08-01 Jean-Loup Huret   Affiliation1.Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France
Clinics and Pathology
Disease
Phenotype stem cell origin
CD30+; ALK+
Epidemiology
at least 7 known cases, aged 12 yrs to 52 yrs (med 23 yrs); no sex unbalance so far, in contrast with the general feature found in ALK+ ALCL
Clinics
ALK+ ALCL without the t(2;5) (so called cytoplasmic only ALK cases) show clinical features similar to those of classical ALK+ ALCL: young age, male predominance, presentation with advanced disease, systemic symptoms, frequent involvement of extranodal sites, and a good prognosis. Nothing in particular is known concerning inv(2) cases, as cases are not fully documented
Prognosis
not well documented
Cytogenetics
Cytogenetics morphological
difficult to identify, as breakpoints lie in telomeric regions; an apparent i(2q) -when present- in ALCL should ring the bell; in some other cases, with numerous anomalies, there is no apparent breakpoint on chromosomes 2.
Cytogenetics molecular
FISH analyses are thereof essential
Additional anomalies
ider(2)(q10)inv(2) has been found in some cases, carrying 2 additional copies of the ATIC-ALK hybrid gene, as detected with FISH; frequent complex karyotypes
Genes Involved and Proteins
Gene name
ALK (anaplastic lymphoma receptor tyrosine kinase)
Location
2p23.2
Protein description
1620 amino acids; 177 kDa; glycoprotein (200 kDa mature protein) ; membrane associated tyrosine kinase receptor
Gene name
ATIC (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase)
Location
2q35
Protein description
591 amino acids, 64 kDa; bifunctional purine biosythesis:9th and 10th step of the de novo purine synthesis
Result of the Chromosomal Anomaly
Description
5 ATIC- 3 ALK791 amino acids, 87 kDa. 229 N-term amino acid from ATIC containing the IMPCH domain and the dimerization domain fused to the 562 C-term amino acids from ALK (i.e. the entire cytoplasmic portion of ALK with the tyrosine kinase domain).
Expression localisation
cytoplasmic localisation (in contrast with the t(2;5)(p23;q35) with NPM1-ALK, which localizes both in the cytoplasm and in the nucleus).
Oncogenesis
ATIC seems to provoke the dimerization of ATIC-ALK, which should lead to constitutive autophosphorylation and activation of the ALK tyrosine kinase, as for NPM1-ALK (see t(2;5)(p23;q35) )
Highly cited references
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 10702393 | 2000 | ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35). | 48 |
| 28659337 | 2017 | Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene. | 48 |
| 11395396 | 2001 | The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells. | 44 |
| 27846861 | 2016 | Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report. | 33 |
| 36910660 | 2023 | Case report: ATIC-ALK fusion in infant-type hemispheric glioma and response to lorlatinib. | 28 |
| 33489809 | 2020 | Coexistence of a novel CCNY-ALK and ATIC-ALK double-fusion in one patient with ALK-positive NSCLC and response to crizotinib: a case report. | 13 |
| 38279625 | 2024 | Variant ALK-fusion positive anaplastic large cell lymphoma (ALCL): A population-based paediatric study of the NHL-BFM study group. | 0 |
| 10706082 | 2000 | A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma. | 0 |
| 18572809 | 2008 | [ATIC-ALK-positive anaplastic large cell lymphoma: a case report and review of the literature]. | 0 |
| 38266918 | 2024 | Molecular Screening in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: Anaplastic Lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling. | 0 |
| 10706887 | 2000 | Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis. | 0 |
| 10994999 | 2000 | Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. | 0 |
| 39109887 | 2025 | Anaplastic large cell lymphoma with ATIC::ALK in leukemic phase and associated with hemophagocytic lymphohistiocytosis. | 0 |
| 38884266 | 2024 | Crizotinib therapy for congenital embryonal rhabdomyosarcoma associated with an ATIC-ALK gene fusion. | 0 |
| 19545284 | 2009 | Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation. | 0 |
| 33246076 | 2021 | Minimal Residual Disease Monitoring Using a 3'ALK Universal Probe Assay in ALK-Positive Anaplastic Large-Cell Lymphoma: ddPCR, an Attractive Alternative Method to Real-Time Quantitative PCR. | 0 |
| 15208656 | 2004 | Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells. | 0 |
| 14631806 | 2003 | [Anaplastic large-cell lymphoma: review]. | 0 |
| 38656257 | 2025 | Inflammatory Myofibroblastic Tumor of the Esophagus and Stomach Successfully Treated With ALK Inhibitor in a Pediatric Patient: A Case Report and Concise Review of Literature. | 0 |
| 26053561 | 2015 | ALK-positive primary cutaneous T-cell-lymphoma (CTCL) with unusual clinical presentation and aggressive course. | 0 |
| 25501114 | 2014 | Variant translocation partners of the anaplastic lymphoma kinase (ALK) gene in two cases of anaplastic large cell lymphoma, identified by inverse cDNA polymerase chain reaction. | 0 |
| 15080301 | 2004 | Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma. | 0 |
| 17464320 | 2007 | Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma. | 0 |
| 12112524 | 2002 | Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. | 0 |
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 10702393 | 2000 | ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35). | Colleoni GW et al |
| 10994999 | 2000 | Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. | Drexler HG et al |
| 10552961 | 1999 | Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. | Falini B et al |
| 9053841 | 1997 | Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. | Iwahara T et al |
| 10706887 | 2000 | Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis. | Ma Z et al |
| 11380391 | 2001 | Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma. | Morris SW et al |
| 11090048 | 2000 | CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. | Stein H et al |
| 10706082 | 2000 | A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma. | Trinei M et al |
| 9763551 | 1998 | The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma. | Wlodarska I et al |
Summary
Fusion gene
ATIC/ALK ATIC (2q35) ALK (2p23.2) COF 444 445 446|ATIC/ALK ATIC (2q35) ALK (2p23.2) M|ATIC/ALK ATIC (2q35) ALK (2p23.2) M inv(2)(p23q35)|ATIC/ALK ATIC (2q35) ALK (2p23.2) TIC
Citation
Jean-Loup Huret
inv(2)(p23q35) ATIC/ALK
Atlas Genet Cytogenet Oncol Haematol. 2001-08-01
Online version: http://atlasgeneticsoncology.org/haematological/1172/inv(2)(p23q35)-atic-alk
